Xvivo Perfusion AB 

$19.00
14
+$0.00+0%Tuesday 14:30

Statistics

Day High
21.8
Day Low
21.8
52W High
30.95
52W Low
17.46
Volume
592
Avg. Volume
66
Mkt Cap
598.48M
P/E Ratio
122.83
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Jan 28Expected
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Q3 2026
Next
0.01
0.05
0.1
0.14
Expected EPS
0.0861548844
Actual EPS
N/A

Financials

3.31%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
85.26MRevenue
2.82MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow XVIPF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap131.57B
Medtronic offers products for cardiac and vascular surgeries, competing in the organ preservation segment.
Boston Scientific
BSX
Mkt Cap64.27B
Boston Scientific competes in the medical devices sector, including technologies for less invasive surgeries.
Stryker
SYK
Mkt Cap117.88B
Stryker provides medical devices for various surgeries, indirectly competing in the organ transplant space.
Intuitive Surgical
ISRG
Mkt Cap153.77B
Intuitive Surgical's robotic-assisted surgical systems can be used in transplant surgeries, offering an alternative to traditional methods.
Edwards Lifesciences
EW
Mkt Cap61.61B
Edwards Lifesciences specializes in heart valves and hemodynamic monitoring, competing in the cardiovascular market.
Abbott Laboratories
ABT
Mkt Cap187.95B
Abbott Laboratories offers medical devices, diagnostics, and nutrition products that serve similar patient groups as XVIVO.
Baxter International
BAX
Mkt Cap13.35B
Baxter International provides a range of hospital and renal products, including organ preservation solutions.
Zimmer Biomet
ZBH
Mkt Cap19.53B
Zimmer Biomet Holdings, Inc. competes in the musculoskeletal healthcare sector, including products that can be used in transplant surgeries.
Johnson & Johnson
JNJ
Mkt Cap687.89B
Johnson & Johnson's medical devices segment offers products that can be used in various surgeries, including organ transplants.
Danaher
DHR
Mkt Cap163.94B
Danaher Corporation's life sciences and diagnostics segments offer products that can be used in the organ transplant process.

About

Xvivo Perfusion AB (publ) is a specialized medtech company creating advanced technologies for the preservation and perfusion of organs, tissues, and cells, vital for successful transplantation. Founded in 1998 and headquartered in Gothenburg, Sweden, the company extends its operations across Sweden, the United States, the broader regions of North and South America, Europe, the Middle East, Africa, and the Asia Pacific. Their product line encompasses the XVIVO System (XPS), an integrated, off-the-shelf cardiac bypass system engineered for secure normothermic ex vivo lung perfusion (EVLP). Accompanying this is the XPS Disposable Lung Kit, supplying necessary sterile disposables and pre-packaged components. They also provide STEEN Solution, a uniquely formulated buffered extracellular solution optimized for perfusing isolated donor lungs during EVLP, and Perfadex Plus, an extracellular, low-potassium, dextran-based electrolyte solution for organ preservation. Additional offerings include the XVIVO Silicone Tubing Set for efficient flushing of donor lungs during procurement, as well as the XVIVO LS and XVIVO Disposable Lung Set, which together constitute a dedicated EVLP device. Furthermore, Xvivo Perfusion supplies the XVIVO Organ Chamber, a single-use sterile disposable container designed as a temporary holding unit for isolated lungs before transplantation, alongside the single-use, sterile XVIVO Lung Cannula Set.
Show More
CEO
Christoffer Rosenblad
Employees
210
Country
Sweden
ISIN
SE0004840718
WKN
000A1J5GZ

Listings

0 Comments

Share your thoughts

FAQs

What is Xvivo Perfusion AB stock price today?▼
The current price of XVIPF is $19.00 USD — it has increased by +0% in the past 24 hours. Watch Xvivo Perfusion AB stock price performance more closely on the chart.
What is Xvivo Perfusion AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Xvivo Perfusion AB stocks are traded under the ticker XVIPF.
Is Xvivo Perfusion AB stock price growing?▼
XVIPF stock has fallen by -5.24% compared to the previous week, the month change is a -12.84% fall, over the last year Xvivo Perfusion AB has showed a +8.85% increase.
What is Xvivo Perfusion AB market cap?▼
Today Xvivo Perfusion AB has the market capitalization of 598.48M
When is the next Xvivo Perfusion AB earnings date?▼
Xvivo Perfusion AB is going to release the next earnings report on January 28, 2027.
What were Xvivo Perfusion AB earnings last quarter?▼
XVIPF earnings for the last quarter are 0.14 USD per share, whereas the estimation was 0.06 USD resulting in a +116.6% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Xvivo Perfusion AB revenue for the last year?▼
Xvivo Perfusion AB revenue for the last year amounts to 85.26M USD.
What is Xvivo Perfusion AB net income for the last year?▼
XVIPF net income for the last year is 2.82M USD.
How many employees does Xvivo Perfusion AB have?▼
As of November 18, 2026, the company has 210 employees.
In which sector is Xvivo Perfusion AB located?▼
Xvivo Perfusion AB operates in the Health & Wellness sector.
When did Xvivo Perfusion AB complete a stock split?▼
Xvivo Perfusion AB has not had any recent stock splits.
Where is Xvivo Perfusion AB headquartered?▼
Xvivo Perfusion AB is headquartered in Mölndal, Sweden.